Erste Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-35,500
| Closed | -$1.83M | – | 969 |
|
|
2022
Q3 | $1.83M | Hold |
35,500
| – | – | 0.04% | 292 |
|
|
2022
Q2 | $905K | Hold |
35,500
| – | – | 0.02% | 366 |
|
|
2022
Q1 | $888K | Buy |
35,500
+19,000
| +115% | +$475K | 0.02% | 368 |
|
|
2021
Q4 | $598K | Hold |
16,500
| – | – | 0.01% | 414 |
|
|
2021
Q3 | $323K | Sell |
16,500
-43,500
| -73% | -$851K | 0.01% | 450 |
|
|
2021
Q2 | $845K | Hold |
60,000
| – | – | 0.02% | 360 |
|
|
2021
Q1 | $2.99M | Hold |
60,000
| – | – | 0.07% | 227 |
|
|
2020
Q4 | $3.69M | Sell |
60,000
-15,000
| -20% | -$922K | 0.1% | 195 |
|
|
2020
Q3 | $4.01M | Buy |
75,000
+7,000
| +10% | +$375K | 0.14% | 169 |
|
|
2020
Q2 | $3.72M | Hold |
68,000
| – | – | 0.15% | 155 |
|
|
2020
Q1 | $2.69M | Hold |
68,000
| – | – | 0.16% | 158 |
|
|
2019
Q4 | $2.46M | Buy |
+68,000
| New | +$2.46M | 0.11% | 186 |
|